Co-Authors
This is a "connection" page, showing publications co-authored by Tomer Israely and Shmuel Yitzhaki.
Connection Strength
0.520
-
A single dose of recombinant VSV-?G-spike vaccine provides protection against SARS-CoV-2 challenge. Nat Commun. 2020 12 16; 11(1):6402.
Score: 0.230
-
The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants. Cell Rep. 2021 09 07; 36(10):109679.
Score: 0.060
-
Mice with induced pulmonary morbidities display severe lung inflammation and mortality following exposure to SARS-CoV-2. JCI Insight. 2021 06 22; 6(12).
Score: 0.060
-
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody. Nat Commun. 2021 02 11; 12(1):944.
Score: 0.058
-
Detection and infectivity potential of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) environmental contamination in isolation units and quarantine facilities. Clin Microbiol Infect. 2020 Dec; 26(12):1658-1662.
Score: 0.056
-
A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes. Nat Commun. 2020 08 27; 11(1):4303.
Score: 0.056